Middle East & Africa Aquatic Veterinary Market Forecast to 2030 - Regional Analysis - by Type (Diagnostic and Treatment), Diagnostic (Serological, Molecular Diagnosis, DNA Sequencing, and Other Diagnostics), Treatment (Vaccines, Medications, and Supplemen

Middle East & Africa Aquatic Veterinary Market Forecast to 2030 - Regional Analysis - by Type (Diagnostic and Treatment), Diagnostic (Serological, Molecular Diagnosis, DNA Sequencing, and Other Diagnostics), Treatment (Vaccines, Medications, and Supplements), Species (Fish, Crustaceans, Mollusca, and Others), Diseases Source (Bacterial, Viral, Parasites, and Others), and Route of Administration (Water Medication, Medicated Feed, and Other Route of Administrations)

The Middle East & Africa aquatic veterinary market was valued at US$ 75.62 million in 2022 and is expected to reach US$ 92.91 million by 2030; it is estimated to register a CAGR of 2.6% from 2022 to 2030.

Technological Advancements in Fish Vaccines Bolster Middle East & Africa Aquatic Veterinary Market

Aquatic farms across the world increasingly rely on vaccinations to manage animal health. The emergence of novel pathogens with extensive antigenic diversity renders conventional vaccines less effective, which encourages researchers to look into new techniques for creating potent vaccines for aquaculture. Subunit or recombinant DNA/RNA particle vaccines are created using modern vaccine technologies, which focus on specific pathogenic components. Recent advancements in vaccines and vaccinology also support efforts made by researchers to find new vaccine candidates to fight fish pathogens such as mycotic and parasitic agents.

Targeting the construct and/or transgene to antigen-receptor cells is a promising way to improve the effectiveness of DNA vaccines against other viral diseases. Molecular assemblies can be used to target dendritic cells (DC) and antigen-presenting cells (APC) in DNA vaccines, producing immunological responses. Another tactic is to encapsulate the DNA vaccine in specific carriers to stimulate transgene and MHC expression. The development of novel vaccines known as recombinant DNA-based vaccines or new-generation vaccines has made extensive use of recombinant DNA (rDNA) technology. Recombinant immunogenic protein vaccines or epitopes purified from vectors carrying the gene of interest produced in prokaryotic or eukaryotic expression systems, peptide vaccines, live vaccines produced by defined genetic manipulations, and microbial vectors carrying gene coding for immunogenic protein and DNA vaccines are among the types of vaccines based on recombinant DNA technology that have been developed. Recombinant vaccines have the advantage of closely simulating naturally occurring infections, which aids in triggering a potent immune response in the treated fish. Moreover, these vaccines can be mass-produced easily. Thus, the development of novel vaccines is emerging as a new trend in the Middle East & Africa aquatic veterinary market.

Middle East & Africa Aquatic Veterinary Market Overview

As per the data provided by the World Bank, aquaculture production in South Africa was 9,753 metric ton in 2020, and it increased to 10,525 metric ton in 2021. In South Africa, the sector is dominated by abalone, trout, and mussels. Good infrastructure developed supply chains, and a supportive aquaculture legislation framework contribute to the rise in demand for aquaculture in the country. The South African aquatic veterinary market is mainly driven by the increasing production volume of aquaculture in the country. In January 2020, the University of Cape Town (UCT) in South Africa launched a collaborative research project that focuses on increasing healthy aquaculture production in sub-Saharan Africa. The One Health project focuses on the research and promotion of healthy feeds in aquaculture to boost the immune systems of fish to counter challenges posed by the spread of various infections in fish farms, which is a major threat to fish production in many African countries. A major objective of the project was to develop a new technology that helps generate antibodies specific to a pathogen that can be used as a therapeutic and diagnostic tool. It also emphasizes on the development of DNA vaccines that can specifically prevent infections in healthy farmed fish. As the aquaculture industry grows, the production of healthy fish also increases, which, in turn, fuels the growth of the Middle East & Africa aquatic veterinary market in South Africa.

Middle East & Africa Aquatic Veterinary Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Aquatic Veterinary Market Segmentation

The Middle East & Africa aquatic veterinary market is categorized into type, species, diseases source, route of administration, and country.

Based on type, the Middle East & Africa aquatic veterinary market is bifurcated diagnostic and treatment. The treatment segment held a larger market share in 2022. The diagnostic segment is further sub segmented into serological, molecular, DNA sequencing, and other diagnostics. The treatment segment is further sub segmented into vaccines, medications, and supplements.

By species, the Middle East & Africa aquatic veterinary market is segmented into fish, crustaceans, mollusca, and others. The fish segment held the largest market share in 2022.

Based on diseases source, the Middle East & Africa aquatic veterinary market is segmented into bacterial, viral, parasites, and others. The bacterial segment held the largest market share in 2022.

In terms of route of administration, the Middle East & Africa aquatic veterinary market is segmented into water medication, medicated feed, and other route of administrations. The water medication segment held the largest market share in 2022.

By country, the Middle East & Africa aquatic veterinary market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa aquatic veterinary market share in 2022.

Aquatic Diagnostics Ltd, Ceva Polchem Pvt Ltd, Elanco Animal Health Inc, HIPRA SA, Merck KGaA, Phibro Animal Health Corp, Thermo Fisher Scientific Inc, Virbac SA, and Zoetis Inc are some of the leading companies operating in the Middle East & Africa aquatic veterinary market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa aquatic veterinary market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa aquatic veterinary market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa aquatic veterinary market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.